These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2569001)

  • 1. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease.
    Brodde OE; Zerkowski HR; Doetsch N; Motomura S; Khamssi M; Michel MC
    J Am Coll Cardiol; 1989 Aug; 14(2):323-31. PubMed ID: 2569001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium.
    Schwinger RH; Böhm M; Pieske B; Erdmann E
    Eur J Clin Invest; 1991 Aug; 21(4):443-51. PubMed ID: 1657613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases.
    Steinfath M; Geertz B; Schmitz W; Scholz H; Haverich A; Breil I; Hanrath P; Reupcke C; Sigmund M; Lo HB
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):217-20. PubMed ID: 1648674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies.
    Motomura S; Reinhard-Zerkowski H; Daul A; Brodde OE
    Am Heart J; 1990 Mar; 119(3 Pt 1):608-19. PubMed ID: 1968697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between myocardial beta-adrenergic receptor and left ventricular function in patients with left ventricular volume overload due to chronic mitral regurgitation with or without aortic regurgitation.
    Sakagoshi N; Nakano S; Taniguchi K; Hirata N; Matsuda H
    Am J Cardiol; 1991 Jul; 68(1):81-4. PubMed ID: 1647656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility?
    Brodde OE; Zerkowski HR
    Basic Res Cardiol; 1989; 84 Suppl 1():135-44. PubMed ID: 2554871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):668-73. PubMed ID: 7905755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor function in heart failure.
    Bogaert MG; Fraeyman N
    Am J Med; 1991 May; 90(5B):10S-13S. PubMed ID: 1646566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors.
    Brodde OE; Zerkowski HR; Borst HG; Maier W; Michel MC
    Eur Heart J; 1989 Jun; 10 Suppl B():38-44. PubMed ID: 2553410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart.
    Brown L; Deighton NM; Bals S; Söhlmann W; Zerkowski HR; Michel MC; Brodde OE
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):222-32. PubMed ID: 1376792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
    Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists?
    Brodde OE
    Eur Heart J; 1991 Dec; 12 Suppl F():54-62. PubMed ID: 1687117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of left ventricular volume and pressure overload on beta-adrenoceptor density in left heart valvular disease.
    Dzimiri N; Moorji A; Kumar M; Kumar N; Halees Z
    Int J Cardiol; 1996 Feb; 53(2):109-16. PubMed ID: 8682596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of alpha-adrenoceptor-mediated responses following chronic beta-adrenoceptor stimulation in the rat heart.
    Butterfield MC; Chess-Williams R
    Br J Pharmacol; 1993 Mar; 108(3):658-62. PubMed ID: 8096782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
    Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
    Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    Eur J Clin Pharmacol; 1992; 42(6):607-11. PubMed ID: 1320570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.